Experts call for shift in cervical cancer screening

Dr Ahmed Kalebi, a Kenyan Consultant Pathologist and CEO of Lancet Group of Labs at the just concluded International Papillomavirus Conference (HPV 2017) in Cape Town, South Africa together with Meindert Zwart, President & CEO Rovers Medical Devices. Some experts have called for a shift to HPV testing in combating cervical cancer.

A growing number of local and international experts are calling for a shift in cervical cancer screening to save more lives of women in Kenya and other countries. 

Researchers from Kenya and elsewhere at the just concluded 31st International Papillomavirus Conference (HPV 2017) in Cape Town, South Africa want HPV testing to be the first choice for cervical cancer screening instead of pap smear (PS) and Visual Inspection with Acetic acid (VIA), which are common in Kenya.